Immix Biopharma (IMMX) Minority Interest (2023 - 2024)
Immix Biopharma's (IMMX) quarterly Minority Interest came in at -$283282.0 in Q1 2024, down 775.46% year-on-year from $41939.0 in Q2 2023, and down 40.42% quarter-over-quarter from -$201737.0 in Q4 2023.
Immix Biopharma (IMMX) Minority Interest (2023 - 2024) Analysis & Trends
Immix Biopharma has disclosed Minority Interest across 2 years of filings, most recently posting -$283282.0 for Q1 2024.
- Minority Interest for Q1 2024 came in at -$283282.0, down 775.46% year-over-year; the trailing twelve-month figure through Mar 2024 was -$283282.0 (down 775.46% YoY), and the FY2023 annual result was -$201737.0, changed N/A from the prior year.
- Minority Interest came in at -$283282.0 for Q1 2024 at Immix Biopharma, down from -$201737.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$32358.0 in Q1 2023 to a low of -$283282.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Immix Biopharma | 467.59 Mn | 467.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -283,282.00 |
| Dec 31, 2023 | -201,737.00 |
| Sep 30, 2023 | -124,667.00 |
| Jun 30, 2023 | -56,770.00 |
| Mar 31, 2023 | -32,358.00 |